1 Study Coverage 1.1 Cutaneous Lupus Erythematosus (CLE) Treatment Revenue in Cutaneous Lupus Erythematosus (CLE) Treatment Business (2017-2022) & (US$ Million) Introduction 1.2 Global Cutaneous Lupus Erythematosus (CLE) Treatment Outlook 2017 VS 2022 VS 2028 1.2.1 Global Cutaneous Lupus Erythematosus (CLE) Treatment Market Size for the Year 2017-2028 1.2.2 Global Cutaneous Lupus Erythematosus (CLE) Treatment Market Size for the Year 2017-2028 1.3 Cutaneous Lupus Erythematosus (CLE) Treatment Market Size, United States VS Global, 2017 VS 2022 VS 2028 1.3.1 The Market Share of United States Cutaneous Lupus Erythematosus (CLE) Treatment in Global, 2017 VS 2022 VS 2028 1.3.2 The Growth Rate of Cutaneous Lupus Erythematosus (CLE) Treatment Market Size, United States VS Global, 2017 VS 2022 VS 2028 1.4 Cutaneous Lupus Erythematosus (CLE) Treatment Market Dynamics 1.4.1 Cutaneous Lupus Erythematosus (CLE) Treatment Industry Trends 1.4.2 Cutaneous Lupus Erythematosus (CLE) Treatment Market Drivers 1.4.3 Cutaneous Lupus Erythematosus (CLE) Treatment Market Challenges 1.4.4 Cutaneous Lupus Erythematosus (CLE) Treatment Market Restraints 1.5 Study Objectives 1.6 Years Considered 2 Cutaneous Lupus Erythematosus (CLE) Treatment by Type 2.1 Cutaneous Lupus Erythematosus (CLE) Treatment Market Segment by Type 2.1.1 Topical 2.1.2 Systemic treatments 2.2 Global Cutaneous Lupus Erythematosus (CLE) Treatment Market Size by Type (2017, 2022 & 2028) 2.3 Global Cutaneous Lupus Erythematosus (CLE) Treatment Market Size by Type (2017-2028) 2.4 United States Cutaneous Lupus Erythematosus (CLE) Treatment Market Size by Type (2017, 2022 & 2028) 2.5 United States Cutaneous Lupus Erythematosus (CLE) Treatment Market Size by Type (2017-2028) 3 Cutaneous Lupus Erythematosus (CLE) Treatment by Application 3.1 Cutaneous Lupus Erythematosus (CLE) Treatment Market Segment by Application 3.1.1 Hospitals 3.1.2 Drugstores 3.1.3 Others 3.2 Global Cutaneous Lupus Erythematosus (CLE) Treatment Market Size by Application (2017, 2022 & 2028) 3.3 Global Cutaneous Lupus Erythematosus (CLE) Treatment Market Size by Application (2017-2028) 3.4 United States Cutaneous Lupus Erythematosus (CLE) Treatment Market Size by Application (2017, 2022 & 2028) 3.5 United States Cutaneous Lupus Erythematosus (CLE) Treatment Market Size by Application (2017-2028) 4 Global Cutaneous Lupus Erythematosus (CLE) Treatment Competitor Landscape by Company 4.1 Global Cutaneous Lupus Erythematosus (CLE) Treatment Market Size by Company 4.1.1 Top Global Cutaneous Lupus Erythematosus (CLE) Treatment Companies Ranked by Revenue (2021) 4.1.2 Global Cutaneous Lupus Erythematosus (CLE) Treatment Revenue by Player (2017-2022) 4.2 Global Cutaneous Lupus Erythematosus (CLE) Treatment Concentration Ratio (CR) 4.2.1 Cutaneous Lupus Erythematosus (CLE) Treatment Market Concentration Ratio (CR) (2017-2022) 4.2.2 Global Top 5 and Top 10 Largest Companies of Cutaneous Lupus Erythematosus (CLE) Treatment in 2021 4.2.3 Global Cutaneous Lupus Erythematosus (CLE) Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 4.3 Global Cutaneous Lupus Erythematosus (CLE) Treatment Headquarters, Revenue in Cutaneous Lupus Erythematosus (CLE) Treatment Business (2017-2022) & (US$ Million) Type 4.3.1 Global Cutaneous Lupus Erythematosus (CLE) Treatment Headquarters and Area Served 4.3.2 Global Cutaneous Lupus Erythematosus (CLE) Treatment Companies Revenue in Cutaneous Lupus Erythematosus (CLE) Treatment Business (2017-2022) & (US$ Million) Type 4.3.3 Date of International Companies Enter into Cutaneous Lupus Erythematosus (CLE) Treatment Market 4.4 Companies Mergers & Acquisitions, Expansion Plans 4.5 United States Cutaneous Lupus Erythematosus (CLE) Treatment Market Size by Company 4.5.1 Top Cutaneous Lupus Erythematosus (CLE) Treatment Players in United States, Ranked by Revenue (2021) 4.5.2 United States Cutaneous Lupus Erythematosus (CLE) Treatment Revenue by Players (2020, 2021 & 2022) 5 Global Cutaneous Lupus Erythematosus (CLE) Treatment Market Size by Region 5.1 Global Cutaneous Lupus Erythematosus (CLE) Treatment Market Size by Region: 2017 VS 2022 VS 2028 5.2 Global Cutaneous Lupus Erythematosus (CLE) Treatment Market Size by Region (2017-2028) 5.2.1 Global Cutaneous Lupus Erythematosus (CLE) Treatment Market Size by Region: 2017-2022 5.2.2 Global Cutaneous Lupus Erythematosus (CLE) Treatment Market Size by Region (2023-2028) 6 Segment in Region Level & Country Level 6.1 North America 6.1.1 North America Cutaneous Lupus Erythematosus (CLE) Treatment Market Size YoY Growth 2017-2028 6.1.2 North America Cutaneous Lupus Erythematosus (CLE) Treatment Market Facts & Figures by Country (2017, 2022 & 2028) 6.1.3 U.S. 6.1.4 Canada 6.2 Asia-Pacific 6.2.1 Asia-Pacific Cutaneous Lupus Erythematosus (CLE) Treatment Market Size YoY Growth 2017-2028 6.2.2 Asia-Pacific Cutaneous Lupus Erythematosus (CLE) Treatment Market Facts & Figures by Region (2017, 2022 & 2028) 6.2.3 China 6.2.4 Japan 6.2.5 South Korea 6.2.6 India 6.2.7 Australia 6.2.8 Taiwan 6.2.9 Indonesia 6.2.10 Thailand 6.2.11 Malaysia 6.2.12 Philippines 6.3 Europe 6.3.1 Europe Cutaneous Lupus Erythematosus (CLE) Treatment Market Size YoY Growth 2017-2028 6.3.2 Europe Cutaneous Lupus Erythematosus (CLE) Treatment Market Facts & Figures by Country (2017, 2022 & 2028) 6.3.3 Germany 6.3.4 France 6.3.5 U.K. 6.3.6 Italy 6.3.7 Russia 6.4 Latin America 6.4.1 Latin America Cutaneous Lupus Erythematosus (CLE) Treatment Market Size YoY Growth 2017-2028 6.4.2 Latin America Cutaneous Lupus Erythematosus (CLE) Treatment Market Facts & Figures by Country (2017, 2022 & 2028) 6.4.3 Mexico 6.4.4 Brazil 6.4.5 Argentina 6.5 Middle East and Africa 6.5.1 Middle East and Africa Cutaneous Lupus Erythematosus (CLE) Treatment Market Size YoY Growth 2017-2028 6.5.2 Middle East and Africa Cutaneous Lupus Erythematosus (CLE) Treatment Market Facts & Figures by Country (2017, 2022 & 2028) 6.5.3 Turkey 6.5.4 Saudi Arabia 6.5.5 UAE 7 Company Profiles 7.1 GSK 7.1.1 GSK Company Details 7.1.2 GSK Business Overview 7.1.3 GSK Cutaneous Lupus Erythematosus (CLE) Treatment Introduction 7.1.4 GSK Revenue in Cutaneous Lupus Erythematosus (CLE) Treatment Business (2017-2022) 7.1.5 GSK Recent Development 7.2 Pfizer 7.2.1 Pfizer Company Details 7.2.2 Pfizer Business Overview 7.2.3 Pfizer Cutaneous Lupus Erythematosus (CLE) Treatment Introduction 7.2.4 Pfizer Revenue in Cutaneous Lupus Erythematosus (CLE) Treatment Business (2017-2022) 7.2.5 Pfizer Recent Development 7.3 AstraZeneca 7.3.1 AstraZeneca Company Details 7.3.2 AstraZeneca Business Overview 7.3.3 AstraZeneca Cutaneous Lupus Erythematosus (CLE) Treatment Introduction 7.3.4 AstraZeneca Revenue in Cutaneous Lupus Erythematosus (CLE) Treatment Business (2017-2022) 7.3.5 AstraZeneca Recent Development 7.4 ImmuPharma 7.4.1 ImmuPharma Company Details 7.4.2 ImmuPharma Business Overview 7.4.3 ImmuPharma Cutaneous Lupus Erythematosus (CLE) Treatment Introduction 7.4.4 ImmuPharma Revenue in Cutaneous Lupus Erythematosus (CLE) Treatment Business (2017-2022) 7.4.5 ImmuPharma Recent Development 7.5 Biogen 7.5.1 Biogen Company Details 7.5.2 Biogen Business Overview 7.5.3 Biogen Cutaneous Lupus Erythematosus (CLE) Treatment Introduction 7.5.4 Biogen Revenue in Cutaneous Lupus Erythematosus (CLE) Treatment Business (2017-2022) 7.5.5 Biogen Recent Development 7.6 Viela Bio 7.6.1 Viela Bio Company Details 7.6.2 Viela Bio Business Overview 7.6.3 Viela Bio Cutaneous Lupus Erythematosus (CLE) Treatment Introduction 7.6.4 Viela Bio Revenue in Cutaneous Lupus Erythematosus (CLE) Treatment Business (2017-2022) 7.6.5 Viela Bio Recent Development 7.7 Roche 7.7.1 Roche Company Details 7.7.2 Roche Business Overview 7.7.3 Roche Cutaneous Lupus Erythematosus (CLE) Treatment Introduction 7.7.4 Roche Revenue in Cutaneous Lupus Erythematosus (CLE) Treatment Business (2017-2022) 7.7.5 Roche Recent Development 7.8 Bristol-Myers Squibb 7.8.1 Bristol-Myers Squibb Company Details 7.8.2 Bristol-Myers Squibb Business Overview 7.8.3 Bristol-Myers Squibb Cutaneous Lupus Erythematosus (CLE) Treatment Introduction 7.8.4 Bristol-Myers Squibb Revenue in Cutaneous Lupus Erythematosus (CLE) Treatment Business (2017-2022) 7.8.5 Bristol-Myers Squibb Recent Development 8 Research Findings and Conclusion 9 Appendix 9.1 Research Methodology 9.1.1 Methodology/Research Approach 9.1.2 Data Source 9.2 Author Details 9.3 Disclaimer

List of Tables Table 1. Cutaneous Lupus Erythematosus (CLE) Treatment Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028) Table 2. Cutaneous Lupus Erythematosus (CLE) Treatment Market Trends Table 3. Cutaneous Lupus Erythematosus (CLE) Treatment Market Drivers Table 4. Cutaneous Lupus Erythematosus (CLE) Treatment Market Challenges Table 5. Cutaneous Lupus Erythematosus (CLE) Treatment Market Restraints Table 6. Global Cutaneous Lupus Erythematosus (CLE) Treatment Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million) Table 7. United States Cutaneous Lupus Erythematosus (CLE) Treatment Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million) Table 8. Global Cutaneous Lupus Erythematosus (CLE) Treatment Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million) Table 9. United States Cutaneous Lupus Erythematosus (CLE) Treatment Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million) Table 10. Top Cutaneous Lupus Erythematosus (CLE) Treatment Companies in Global Market, Ranking by Revenue (2021) Table 11. Global Cutaneous Lupus Erythematosus (CLE) Treatment Revenue by Player, (US$ Million), 2017-2022 Table 12. Global Cutaneous Lupus Erythematosus (CLE) Treatment Revenue Share by Player, 2017-2022 Table 13. Global Cutaneous Lupus Erythematosus (CLE) Treatment Companies Market Concentration Ratio (CR5 and HHI) Table 14. Global Cutaneous Lupus Erythematosus (CLE) Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cutaneous Lupus Erythematosus (CLE) Treatment as of 2021) Table 15. Top Players of Cutaneous Lupus Erythematosus (CLE) Treatment in Global Market, Headquarters and Area Served Table 16. Companies Revenue in Cutaneous Lupus Erythematosus (CLE) Treatment Business (2017-2022) & (US$ Million) Type Table 17. Date of International Companies Enter into Cutaneous Lupus Erythematosus (CLE) Treatment Market Table 18. Companies Mergers & Acquisitions, Expansion Plans Table 19. Top Cutaneous Lupus Erythematosus (CLE) Treatment Players in United States Market, Ranking by Revenue (2021) Table 20. United States Cutaneous Lupus Erythematosus (CLE) Treatment Revenue by Players, (US$ Million), 2020, 2021 & 2022 Table 21. United States Cutaneous Lupus Erythematosus (CLE) Treatment Revenue Share by Players, 2020, 2021 & 2022 Table 22. Global Cutaneous Lupus Erythematosus (CLE) Treatment Market Size by Region (US$ Million): 2017 VS 2022 VS 2028 Table 23. Global Cutaneous Lupus Erythematosus (CLE) Treatment Market Size by Region (2017-2022) & (US$ Million) Table 24. Global Cutaneous Lupus Erythematosus (CLE) Treatment Market Size Forecast by Region (2023-2028) & (US$ Million) Table 25. North America Cutaneous Lupus Erythematosus (CLE) Treatment Sales in Value by Country (2017-2028) & (US$ Million) Table 26. Asia Pacific Cutaneous Lupus Erythematosus (CLE) Treatment Sales in Value by Region (2017-2028) & (US$ Million) Table 27. Europe Cutaneous Lupus Erythematosus (CLE) Treatment Sales in Value by Country (2017-2028) & (US$ Million) Table 28. Latin Americaa Cutaneous Lupus Erythematosus (CLE) Treatment Sales in Value by Country (2017-2028) & (US$ Million) Table 29. Middle East and Africa Cutaneous Lupus Erythematosus (CLE) Treatment Sales in Value by Country (2017-2028) & (US$ Million) Table 30. GSK Company Details Table 31. GSK Business Overview Table 32. GSK Cutaneous Lupus Erythematosus (CLE) Treatment Product Table 33. GSK Revenue in Cutaneous Lupus Erythematosus (CLE) Treatment Business (2017-2022) & (US$ Million) Table 34. GSK Recent Development Table 35. Pfizer Company Details Table 36. Pfizer Business Overview Table 37. Pfizer Cutaneous Lupus Erythematosus (CLE) Treatment Product Table 38. Pfizer Revenue in Cutaneous Lupus Erythematosus (CLE) Treatment Business (2017-2022) & (US$ Million) Table 39. Pfizer Recent Development Table 40. AstraZeneca Company Details Table 41. AstraZeneca Business Overview Table 42. AstraZeneca Cutaneous Lupus Erythematosus (CLE) Treatment Product Table 43. AstraZeneca Revenue in Cutaneous Lupus Erythematosus (CLE) Treatment Business (2017-2022) & (US$ Million) Table 44. AstraZeneca Recent Development Table 45. ImmuPharma Company Details Table 46. ImmuPharma Business Overview Table 47. ImmuPharma Cutaneous Lupus Erythematosus (CLE) Treatment Product Table 48. ImmuPharma Revenue in Cutaneous Lupus Erythematosus (CLE) Treatment Business (2017-2022) & (US$ Million) Table 49. ImmuPharma Recent Development Table 50. Biogen Company Details Table 51. Biogen Business Overview Table 52. Biogen Cutaneous Lupus Erythematosus (CLE) Treatment Product Table 53. Biogen Revenue in Cutaneous Lupus Erythematosus (CLE) Treatment Business (2017-2022) & (US$ Million) Table 54. Biogen Recent Development Table 55. Viela Bio Company Details Table 56. Viela Bio Business Overview Table 57. Viela Bio Cutaneous Lupus Erythematosus (CLE) Treatment Product Table 58. Viela Bio Revenue in Cutaneous Lupus Erythematosus (CLE) Treatment Business (2017-2022) & (US$ Million) Table 59. Viela Bio Recent Development Table 60. Roche Company Details Table 61. Roche Business Overview Table 62. Roche Cutaneous Lupus Erythematosus (CLE) Treatment Product Table 63. Roche Revenue in Cutaneous Lupus Erythematosus (CLE) Treatment Business (2017-2022) & (US$ Million) Table 64. Roche Recent Development Table 65. Bristol-Myers Squibb Company Details Table 66. Bristol-Myers Squibb Business Overview Table 67. Bristol-Myers Squibb Cutaneous Lupus Erythematosus (CLE) Treatment Product Table 68. Bristol-Myers Squibb Revenue in Cutaneous Lupus Erythematosus (CLE) Treatment Business (2017-2022) & (US$ Million) Table 69. Bristol-Myers Squibb Recent Development Table 70. Research Programs/Design for This Report Table 71. Key Data Information from Secondary Sources Table 72. Key Data Information from Primary Sources List of Figures Figure 1. Cutaneous Lupus Erythematosus (CLE) Treatment Product Picture Figure 2. Global Cutaneous Lupus Erythematosus (CLE) Treatment Market Size, (US$ Million), 2017 VS 2022 VS 2028 Figure 3. Global Cutaneous Lupus Erythematosus (CLE) Treatment Market Size 2017-2028 (US$ Million) Figure 4. United States Cutaneous Lupus Erythematosus (CLE) Treatment Market Size, (US$ Million), 2017 VS 2022 VS 2028 Figure 5. United States Cutaneous Lupus Erythematosus (CLE) Treatment Market Size 2017-2028 (US$ Million) Figure 6. United States Cutaneous Lupus Erythematosus (CLE) Treatment Market Share in Global 2017-2028 Figure 7. Cutaneous Lupus Erythematosus (CLE) Treatment Report Years Considered Figure 8. Product Picture of Topical Figure 9. Product Picture of Systemic treatments Figure 10. Global Cutaneous Lupus Erythematosus (CLE) Treatment Market Share by Type in 2022 & 2028 Figure 11. Global Cutaneous Lupus Erythematosus (CLE) Treatment Market Size by Type (2017-2028) & (US$ Million) Figure 12. Global Cutaneous Lupus Erythematosus (CLE) Treatment Market Share by Type (2017-2028) Figure 13. United States Cutaneous Lupus Erythematosus (CLE) Treatment Market Share by Type in 2022 & 2028 Figure 14. United States Cutaneous Lupus Erythematosus (CLE) Treatment Market Size by Type (2017-2028) & (US$ Million) Figure 15. United States Cutaneous Lupus Erythematosus (CLE) Treatment Market Share by Type (2017-2028) Figure 16. Product Picture of Hospitals Figure 17. Product Picture of Drugstores Figure 18. Product Picture of Others Figure 19. Global Cutaneous Lupus Erythematosus (CLE) Treatment Market Share by Application in 2022 & 2028 Figure 20. Global Cutaneous Lupus Erythematosus (CLE) Treatment Market Size by Application (2017-2028) & (US$ Million) Figure 21. Global Cutaneous Lupus Erythematosus (CLE) Treatment Market Share by Application (2017-2028) Figure 22. United States Cutaneous Lupus Erythematosus (CLE) Treatment Market Share by Application in 2022 & 2028 Figure 23. United States Cutaneous Lupus Erythematosus (CLE) Treatment Market Size by Application (2017-2028) & (US$ Million) Figure 24. United States Cutaneous Lupus Erythematosus (CLE) Treatment Market Share by Application (2017-2028) Figure 25. North America Cutaneous Lupus Erythematosus (CLE) Treatment Market Size Growth Rate 2017-2028 (US$ Million) Figure 26. U.S. Cutaneous Lupus Erythematosus (CLE) Treatment Market Size Growth Rate (2017-2028) & (US$ Million) Figure 27. Canada Cutaneous Lupus Erythematosus (CLE) Treatment Market Size Growth Rate (2017-2028) & (US$ Million) Figure 28. Europe Cutaneous Lupus Erythematosus (CLE) Treatment Market Size Growth Rate 2017-2028 (US$ Million) Figure 29. Germany Cutaneous Lupus Erythematosus (CLE) Treatment Market Size Growth Rate (2017-2028) & (US$ Million) Figure 30. France Cutaneous Lupus Erythematosus (CLE) Treatment Market Size Growth Rate (2017-2028) & (US$ Million) Figure 31. U.K. Cutaneous Lupus Erythematosus (CLE) Treatment Market Size Growth Rate (2017-2028) & (US$ Million) Figure 32. Italy Cutaneous Lupus Erythematosus (CLE) Treatment Market Size Growth Rate (2017-2028) & (US$ Million) Figure 33. Russia Cutaneous Lupus Erythematosus (CLE) Treatment Market Size Growth Rate (2017-2028) & (US$ Million) Figure 34. Asia-Pacific Cutaneous Lupus Erythematosus (CLE) Treatment Market Size Growth Rate 2017-2028 (US$ Million) Figure 35. China Cutaneous Lupus Erythematosus (CLE) Treatment Market Size Growth Rate (2017-2028) & (US$ Million) Figure 36. Japan Cutaneous Lupus Erythematosus (CLE) Treatment Market Size Growth Rate (2017-2028) & (US$ Million) Figure 37. South Korea Cutaneous Lupus Erythematosus (CLE) Treatment Market Size Growth Rate (2017-2028) & (US$ Million) Figure 38. India Cutaneous Lupus Erythematosus (CLE) Treatment Market Size Growth Rate (2017-2028) & (US$ Million) Figure 39. Australia Cutaneous Lupus Erythematosus (CLE) Treatment Market Size Growth Rate (2017-2028) & (US$ Million) Figure 40. Taiwan Cutaneous Lupus Erythematosus (CLE) Treatment Market Size Growth Rate (2017-2028) & (US$ Million) Figure 41. Indonesia Cutaneous Lupus Erythematosus (CLE) Treatment Market Size Growth Rate (2017-2028) & (US$ Million) Figure 42. Thailand Cutaneous Lupus Erythematosus (CLE) Treatment Market Size Growth Rate (2017-2028) & (US$ Million) Figure 43. Malaysia Cutaneous Lupus Erythematosus (CLE) Treatment Market Size Growth Rate (2017-2028) & (US$ Million) Figure 44. Philippines Cutaneous Lupus Erythematosus (CLE) Treatment Market Size Growth Rate (2017-2028) & (US$ Million) Figure 45. Latin America Cutaneous Lupus Erythematosus (CLE) Treatment Market Size Growth Rate 2017-2028 (US$ Million) Figure 46. Mexico Cutaneous Lupus Erythematosus (CLE) Treatment Market Size Growth Rate (2017-2028) & (US$ Million) Figure 47. Brazil Cutaneous Lupus Erythematosus (CLE) Treatment Market Size Growth Rate (2017-2028) & (US$ Million) Figure 48. Argentina Cutaneous Lupus Erythematosus (CLE) Treatment Market Size Growth Rate (2017-2028) & (US$ Million) Figure 49. Middle East & Africa Cutaneous Lupus Erythematosus (CLE) Treatment Market Size Growth Rate 2017-2028 (US$ Million) Figure 50. Turkey Cutaneous Lupus Erythematosus (CLE) Treatment Market Size Growth Rate (2017-2028) & (US$ Million) Figure 51. Saudi Arabia Cutaneous Lupus Erythematosus (CLE) Treatment Market Size Growth Rate (2017-2028) & (US$ Million) Figure 52. UAE Cutaneous Lupus Erythematosus (CLE) Treatment Market Size Growth Rate (2017-2028) & (US$ Million) Figure 53. GSK Revenue Growth Rate in Cutaneous Lupus Erythematosus (CLE) Treatment Business (2017-2022) Figure 54. Pfizer Revenue Growth Rate in Cutaneous Lupus Erythematosus (CLE) Treatment Business (2017-2022) Figure 55. AstraZeneca Revenue Growth Rate in Cutaneous Lupus Erythematosus (CLE) Treatment Business (2017-2022) Figure 56. ImmuPharma Revenue Growth Rate in Cutaneous Lupus Erythematosus (CLE) Treatment Business (2017-2022) Figure 57. Biogen Revenue Growth Rate in Cutaneous Lupus Erythematosus (CLE) Treatment Business (2017-2022) Figure 58. Viela Bio Revenue Growth Rate in Cutaneous Lupus Erythematosus (CLE) Treatment Business (2017-2022) Figure 59. Roche Revenue Growth Rate in Cutaneous Lupus Erythematosus (CLE) Treatment Business (2017-2022) Figure 60. Bristol-Myers Squibb Revenue Growth Rate in Cutaneous Lupus Erythematosus (CLE) Treatment Business (2017-2022) Figure 61. Bottom-up and Top-down Approaches for This Report Figure 62. Data Triangulation Figure 63. Key Executives Interviewed

GSK Pfizer AstraZeneca ImmuPharma Biogen Viela Bio Roche Bristol-Myers Squibb